Abstract:Background: Major depressive disorder (MDD) is a type of emotional dysfunction, and its pathogenesis has not been fully elucidated. Specifically, the key molecules in depression-related brain regions involved in this disease and their contributions to this disease are currently unclear. Methods: GSE53987 and GSE54568 were selected from the Gene Expression Omnibus database. The data were standardized to identify the common differentially expressed genes (DEGs) in the cortex of MDD patients in the 2 datasets. The DEGs were subjected to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. The STRING database was used to build protein-protein interaction networks, and the cytoHubba plugin was used to identify hub genes. Furthermore, we selected another blood transcriptome dataset that included 161 MDD and 169 control samples to explore the changes in the screened hub genes. Mice were subjected to 4 weeks of chronic unpredictable mild stress to establish an animal model of depression, and the expression of these hub genes in tissues of the prefrontal cortex was then detected by quantitative real time polymerase chain reaction (qRT-PCR). We subsequently predicted the possible posttranscriptional regulatory networks and traditional Chinese medicine according to the hub genes using a few online databases. Results: The analysis identified 147 upregulated genes and 402 downregulated genes were identified in the cortex of MDD patients compared with that of the controls. Enrichment analyses revealed that DEGs were predominantly enriched in synapse-related cell functions, linoleic acid metabolism, and other pathways. Protein-protein interaction analysis identified 20 hub genes based on the total score. The changes in KDM6B, CUX2, NAAA, PHKB, NFYA, GTF2H1, CRK, CCNG2, ACER3, and SLC4A2 in the peripheral blood of MDD patients were consistent with those in the brain. Furthermore, the prefrontal cortex of mice with depressive-like behaviors showed significantly increased Kdm6b, Aridb1, Scaf11, and Thoc2 expression and decreased Ccng2 expression compared with that of normal mice, which was consistent with the results found for the human brain. Potential therapeutic candidates, such as citron, fructus citri, leaves of Panax Notoginseng, sanchi flower, pseudoginseng, and dan-shen root, were selected via traditional Chinese medicine screening. Conclusions: This study identified several novel hub genes in specific brain regions involved in the pathogenesis of MDD, which may not only deepen our understanding of depression but may also provide new ideas for its diagnosis and treatment.

Identification of the Shared Molecular Mechanisms Between Major Depressive Disorder and COVID-19 from Postmortem Brain Transcriptome Analysis.

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Key Risk Genes Identified From the Postmortem Brain of Patients With Major Depressive Disorder and Their Potential Clinical Applications

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Identification of Major Depressive Disorder Disease-Related Genes and Functional Pathways Based on System Dynamic Changes of Network Connectivity.

Identifying Key Biomarkers and Therapeutic Candidates for Post-Covid-19 Depression Through Integrated Omics and Bioinformatics Approaches

A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder

Identification of Key Genes and the Pathophysiology Associated with Major Depressive Disorder Patients Based on Integrated Bioinformatics Analysis

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Investigation of the shared molecular mechanisms and hub genes between myocardial infarction and depression

Identification of Diagnostic Markers for Major Depressive Disorder by Cross-Validation of Data from Whole Blood Samples.

Exploring potential genes and mechanisms linking erectile dysfunction and depression

Identification of Potential Biomarkers for Major Depressive Disorder: Based on Integrated Bioinformatics and Clinical Validation

Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression: Evidence from transcriptome data

Gene Expression Signatures Differentiating Major Depressive Disorder from Subsyndromal Symptomatic Depression.

Identification and Analyses of Crucial Genes Associated with Pathogenesis of Major Depressive Disorder

Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes

Identification of Common Genes and Screening of Therapeutic Agents for Major Depressive Disorder and Alzheimer's Disease through Integrated Bioinformatics Approach

Exploring the bi-directional relationship and shared genes between depression and stroke via NHANES and bioinformatic analysis

Immune-related gene characterization and biological mechanisms in major depressive disorder revealed based on transcriptomics and network pharmacology

Identification of novel endoplasmic reticulum-related genes and their association with immune cell infiltration in major depressive disorder